Sermorelin vs Ipamorelin: An Overview
Sermorelin and ipamorelin are two of the most frequently referenced growth hormone secretagogues in the research literature, yet they act through entirely distinct receptor systems. This distinction is the central point of comparison for investigators studying the somatotropic axis in controlled, in vitro or preclinical models.
Sermorelin is a truncated growth-hormone-releasing hormone (GHRH) analog corresponding to the first 29 amino acids of endogenous GHRH (1-29). It engages the GHRH receptor on the anterior pituitary. Ipamorelin, by contrast, is a synthetic pentapeptide belonging to the growth-hormone-releasing peptide (GHRP) class, which acts as a ghrelin-receptor (GHS-R1a) agonist. Because the two occupy different receptor families, they are often studied side by side or in combination in receptor-pharmacology research.
This article compares Sermorelin (10mg) and Ipamorelin (10mg) strictly at the level of structure, receptor target, and research context. For research use only; not for human or animal consumption.
Recommended Products
Comparing Mechanisms and Receptors
The defining difference between these two compounds is the receptor pathway each is designed to interrogate. Sermorelin mimics endogenous GHRH and binds the GHRH receptor, a class B G-protein-coupled receptor. Ipamorelin mimics ghrelin’s core motif and binds GHS-R1a, a class A G-protein-coupled receptor. In the research literature, the two pathways are considered complementary, which is why GHRH analogs and GHRPs are frequently examined together.
| Attribute | Sermorelin | Ipamorelin |
|---|---|---|
| Class | GHRH analog (GHRH 1-29) | GHRP / pentapeptide |
| Receptor target | GHRH receptor | Ghrelin receptor (GHS-R1a) |
| Structure | 29-amino-acid peptide | 5-amino-acid peptide |
| Reference basis | Endogenous GHRH sequence | Ghrelin core motif mimetic |
| Selectivity note | Pathway-specific to GHRH-R | Reported high selectivity in literature |
Ipamorelin is often described in research as one of the more selective GHRP-class peptides for its receptor, a characteristic that makes it a common comparator in structure-activity studies. Sermorelin, being a near-native GHRH fragment, is used as a reference tool when modeling GHRH-receptor engagement. Investigators frequently pair a GHRH analog with a GHRP to study the two receptor systems in parallel; a common companion in such comparative frameworks is CJC-1295 no DAC (10mg), another GHRH-analog research tool. Because the compounds differ in length, sequence, and receptor family, their handling, solubility profiles, and stability characteristics are also distinct and should be evaluated independently. For a broader framework on how these secretagogue classes relate, see our pillar overview on growth hormone secretagogues compared.
Selection Factors and Handling
Researchers typically choose between these compounds based on the receptor system under investigation. A study focused on GHRH-receptor pharmacology would reference a GHRH analog such as sermorelin, whereas work targeting the ghrelin-receptor axis would reference a GHRP such as ipamorelin. Comparative and combination designs use both, which is why they are frequently stocked together in a research inventory.
Handling considerations differ by peptide. Lyophilized peptides of this type are generally reconstituted with an appropriate sterile diluent and kept cold; the 5-residue ipamorelin and the 29-residue sermorelin have different molecular weights and therefore different reconstitution mathematics. As with all research peptides, store lyophilized material cold and protected from light, minimize freeze-thaw cycles, and document lot and reconstitution details for reproducibility. Explore Sermorelin (10mg) and Ipamorelin (10mg) for detailed specifications. For research use only.